These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9846837)

  • 21. Anti-PMP22 antibodies in patients with inflammatory neuropathy.
    Gabriel CM; Gregson NA; Hughes RA
    J Neuroimmunol; 2000 May; 104(2):139-46. PubMed ID: 10713353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical correlates of high-titer IgG anti-GM1 antibodies.
    Kornberg AJ; Pestronk A; Bieser K; Ho TW; McKhann GM; Wu HS; Jiang Z
    Ann Neurol; 1994 Feb; 35(2):234-7. PubMed ID: 8109905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-GD1a ganglioside antibodies in peripheral motor syndromes.
    Carpo M; Nobile-Orazio E; Meucci N; Gamba M; Barbieri S; Allaria S; Scarlato G
    Ann Neurol; 1996 Apr; 39(4):539-43. PubMed ID: 8619533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection.
    Irie S; Saito T; Nakamura K; Kanazawa N; Ogino M; Nukazawa T; Ito H; Tamai Y; Kowa H
    J Neuroimmunol; 1996 Aug; 68(1-2):19-26. PubMed ID: 8784256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Ilyas AA; Mithen FA; Dalakas MC; Chen ZW; Cook SD
    J Neurol Sci; 1992 Jan; 107(1):111-21. PubMed ID: 1578228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
    Shimoya K; Ohnishi A; Hashimoto T; Yuki N
    Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-GM1, anti-central myelin proteins, and anti-cardiolipin autoantibodies during plasma-exchange in Guillain-Barré syndrome (GBS).
    Matà S; Avanzi G; Lombardo R; Cepparone F; Pinto F; Lolli F
    J Clin Apher; 1998; 13(4):155-62. PubMed ID: 9886794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated serum levels of endothelial leukocyte adhesion molecules in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Oka N; Akiguchi I; Kawasaki T; Ohnishi K; Kimura J
    Ann Neurol; 1994 May; 35(5):621-4. PubMed ID: 7513983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome.
    Ilyas AA; Mithen FA; Chen ZW; Cook SD
    J Neurol Sci; 1991 Mar; 102(1):67-75. PubMed ID: 1856733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma.
    Weiss MD; Luciano CA; Semino-Mora C; Dalakas MC; Quarles RH
    Neurology; 1998 Dec; 51(6):1738-41. PubMed ID: 9855537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyneuropathies associated with high titre antisulphatide antibodies: characteristics of patients with and without serum monoclonal proteins.
    Lopate G; Parks BJ; Goldstein JM; Yee WC; Friesenhahn GM; Pestronk A
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):581-5. PubMed ID: 9219742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
    Lim JP; Devaux J; Yuki N
    Autoimmun Rev; 2014 Oct; 13(10):1070-8. PubMed ID: 25172243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 301 to 314 amino acid residue of beta-tubulin is not a target epitope for serum IgM antibodies in chronic inflammatory demyelinating polyneuropathy.
    Tagawa Y; Yuki N; Hirata K
    J Neurol Sci; 1999 Feb; 163(1):44-6. PubMed ID: 10223409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b.
    Marfia GA; Pachatz C; Terracciano C; Leone G; Bernardini S; Bernardi G; Massa R
    Neurol Sci; 2005 Dec; 26(5):355-7. PubMed ID: 16388373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ELISA-type titertray assay of IgM anti-GM1 autoantibodies.
    Bech E; Jakobsen J; Orntoft TF
    Clin Chem; 1994 Jul; 40(7 Pt 1):1331-4. PubMed ID: 8013109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships between anti-ganglioside antibodies and clinical characteristics of Guillain-Barré syndrome.
    Irie S; Saito T; Kanazawa N; Nukazawa T; Ito H; Ogino M; Kowa H
    Intern Med; 1997 Sep; 36(9):607-12. PubMed ID: 9313102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-ganglioside antibodies in patients with Guillain Barré syndrome and other neurological disorders.
    Vaishnavi C; Behura C; Prabhakar S; Sharma A; Kharbanda P
    Indian J Med Microbiol; 2013; 31(2):177-9. PubMed ID: 23867676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies].
    Kusunoki S
    Rinsho Shinkeigaku; 1999 Jan; 39(1):93-5. PubMed ID: 10377820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?
    Miyaji K; Shahrizaila N; Umapathi T; Chan YC; Hirata K; Yuki N
    Hum Immunol; 2014 Nov; 75(11):1089-91. PubMed ID: 25286001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.